Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@article{Garcia:2021:10.1016/j.lungcan.2021.03.005,
author = {Garcia, Campelo MR and Lin, HM and Zhu, Y and Perol, M and Jahanzeb, M and Popat, S and Zhang, P and Camidge, DR},
doi = {10.1016/j.lungcan.2021.03.005},
journal = {LUNG CANCER},
pages = {68--77},
title = {Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK plus non-small cell lung cancer (ALTA-1L)},
url = {http://dx.doi.org/10.1016/j.lungcan.2021.03.005},
volume = {155},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Garcia,Campelo MR
AU - Lin,HM
AU - Zhu,Y
AU - Perol,M
AU - Jahanzeb,M
AU - Popat,S
AU - Zhang,P
AU - Camidge,DR
DO - 10.1016/j.lungcan.2021.03.005
EP - 77
PY - 2021///
SN - 0169-5002
SP - 68
TI - Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK plus non-small cell lung cancer (ALTA-1L)
T2 - LUNG CANCER
UR - http://dx.doi.org/10.1016/j.lungcan.2021.03.005
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000644431300010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 155
ER -